Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

Published:2021-05-05 Issue:5 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Taylor-Rowan Martin¹,Edwards Sophie²,Noel-Storr Anna H³,McCleery Jenny⁴,Myint Phyo K⁵,Soiza Roy⁶,Stewart Carrie⁷,Loke Yoon Kong⁸,Quinn Terry J¹

Affiliation:

1. Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

2. University of Glasgow; Glasgow UK

3. Radcliffe Department of Medicine; University of Oxford; Oxford UK

4. Oxford Health NHS Foundation Trust; Banbury UK

5. Division of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition; University of Aberdeen; Aberdeen UK

6. Department of General Internal Medicine; Aberdeen Royal Infirmary, NHS Grampian; Aberdeen UK

7. ACER; IAHS, University of Aberdeen; Aberdeen UK

8. Norwich Medical School; University of East Anglia; Norwich UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference138 articles.

1. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study;Ancelin;BMJ,2006

2. Association of anticholinergic drug burden with cognitive and functional decline over time in older inpatients: results from the CRIME Project;Brombo;Drugs & Aging,2018

3. Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population;Campbell;Pharmacotherapy,2016

4. Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults;Chuang;Alzheimer's & Dementia,2017

5. Anticholinergic drug exposure and the risk of dementia: a nested case-control study;Coupland;JAMA Internal Medicine,2019

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional anticholinergic activity of drugs classified as strong and moderate on the anticholinergic burden scale on bladder and ileum;Basic & Clinical Pharmacology & Toxicology;2024-09

2. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

3. Drug burden index of people ageing with intellectual disability and cognitive complaints attending a specialist memory service;Journal of Intellectual Disability Research;2024-08-26

4. Impact of cumulative exposure to anticholinergic and sedative drugs on cognition in older adults: a memory clinic cohort study;Alzheimer's Research & Therapy;2024-07-23

5. Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study;International Journal of Clinical Pharmacy;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3